More people in Poland willing to take AstraZeneca shot, says PM

Published
0

Poland is seeing an increase in people willing to take AstraZeneca's Covid-19 vaccine, the prime minister said on Monday, after reports that some people had been unwilling to get the jab due to concerns about side effects, according to Reuters.

After briefly halting its use, many European countries have resumed using the AstraZeneca vaccine in their inoculation programmes after a European Union regulator said it was safe. Poland did not suspend its use it at any stage, arguing that the benefits of the vaccine outweighed potential risks.

“In the morning I got a report ... showing that there are more and more people willing to get vaccinated and also to get vaccinated with the AstraZeneca vaccine,” Mateusz Morawiecki told a news conference.

“This shows that we made the right decision not to suspend vaccinations with AstraZeneca, there are definitely more people willing to be vaccinated with this vaccine,” he added.

Opinion

Editorial

Yemen offensive
Updated 04 Oct, 2026

Yemen offensive

The best option, therefore, is for Muslim and Arab states to help restore the Saudi-Houthi ceasefire.
Growth transition
04 Oct, 2026

Growth transition

PRIME Minister Shehbaz Sharif’s recent call to move from stabilisation to growth, job creation and export ...
Protection at risk
04 Oct, 2026

Protection at risk

THE recent warning from UNHCR should alarm donor governments. Nearly 8.3m refugees and other forcibly displaced...
Talks, at last
Updated 03 Oct, 2026

Talks, at last

The government’s constant threats to suspend KP’s elected dispensation over a political protest have escalated hostilities considerably. In that context, both sides did well to start talking.
IWT’s future
Updated 03 Oct, 2026

IWT’s future

TOGETHER with the Kashmir dispute, India’s unilateral suspension of the Indus Waters Treaty has become the biggest...
Pained minds
03 Oct, 2026

Pained minds

IN Pakistan, mental healthcare is wedged between two extremes — a luxury or a stigma. Estimates cited by the...